RACHEL DEARING: Open Payments
NPI 1043508906 · TALBOTT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 41 payments from 13 companies in 2025. Trend: 2023 $942 · 2024 $1,197 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $279 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| Sage Therapeutics, LLC | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Novo Nordisk Inc | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 1 | $48 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| PFIZER INC. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
Products named: UBRELVY, QULIPTA, Symbravo, VRAYLAR, ZURZUVAE, CAPLYTA, AIRSUPRA, NURTEC ODT.
Industry payments across TN — which companies pay providers there.
